Company
News and press
As a thought leader in the technology space, GATC Health is committed to remaining at the forefront of innovation. Here’s our latest happenings, updates, and industry recognition.
Drug Target Review Features the Science Behind GATC’s New Addiction Drug Candidate
July 23, 2026 — A new feature in Drug Target Review explores the science and data behind GATC Health’s discovery of a potential new …
The Future of AI-Driven Drug Development Featured in Digital Health Insights
July 23, 2026 — GATC Health President Dr. Rahul Gupta is featured prominently throughout a new article published by Digital Health Insights…
GATC Health Experts Featured in Two High-Profile Panels at BIO International 2026
July 7, 2026 — GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development,…
GATC Health Showcases Digital Twin Innovations at Sanofi
June 25, 2026 — This month, GATC Health had the privilege of participating in a focused, high-level presentation at Sanofi’s Cambridge…
GATC Health Takes the Stage at the DIA Global Annual Meeting—Life Sciences’ Largest Event
June 24, 2026 — Last week at the DIA Global Annual Meeting in Philadelphia, GATC Health President Dr. Rahul Gupta joined an estee…
Science Behind GATC-1021 Featured in Physicians Weekly
June 19, 2026 — A new feature in Physician’s Weekly explores the clinical science behind the discovery of GATC-1021, a…
GATC Health Featured in The Dominion Post
June 18, 2026 — A recent article in The Dominion Post featured GATC Health’s Chief Business Officer, Tyrone Lam, and Senior …
GATC Health Featured on Citeline’s In Vivo Podcast: A “FICO Score” for Drug Development
June 17, 2026 — In the episode, titled “GATC Health’s Derisq AI, A FICO Score For Drug Development,” GATC Health Chief Business Officer Ty…
Invite-Only Webinar: Pioneering the Future of Biotech Financing
June 10, 2026 — You are invited to watch an exclusive, pre-recorded webinar detailing a groundbreaking new biotech financing…
